Government and Drug Makers Face with Seven Lawsuits over PPA Incident

Published: 2005-01-21 06:58:00

Updated: 2005-01-21 06:58:00

The pharmaceutical industry is making a close observation on the on-going litigation process involving last year's ban on the production and sale of cold remedies containing phenylpropanolamine (PPA), which led to subsequent lawsuits filed by the public against the government and the manufacturer...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK